Long-Term Survival in Repaired TOF is Excellent
|
By HospiMedica International staff writers Posted on 14 Jan 2019 |

Image: A new study shows Tetralogy of Fallot (TOF) repair has good long-term results (Photo courtesy of MedMovie).
A new study shows that the 25-year survival rate of surgical tetralogy of Fallot (TOF) patients is primarily influenced by the coexistence of an associated genetic condition.
Researchers at Emory University (Atlanta, GA, USA), the University of Minnesota (UMN; Minneapolis, USA), and other institutions conducted a retrospective cohort study involving 3,283 patients (56.4% men) enrolled in the Pediatric Cardiac Care Consortium (PCCC) between 1982 and 2003 and whom survived surgical repair of simple TOF. Main outcomes and measures were transplant-free survival during the early (less than six years) and late phase following surgical repair, adjusted for era and patient characteristics.
The results revealed that one-year survival rate following TOF repair was 98.6%, decreasing to 97.8% at five years; 97.1% at 10 years; 95.5% at 20 years; and 94.5% at 25 years, with an early steep mortality hazard increase peaking shortly after repair, followed by a late, gradual hazard increase. Increased mortality risks were found in non-valve-sparing operations and staged repair. Genetic abnormalities were associated with increased mortality risk in both early and late post-surgical phases. The study was published on December 19, 2018, in JAMA Cardiology.
“Long-term transplant-free survival beyond the first six years is influenced primarily by the coexistence of an associated genetic condition. Within the 25-year follow-up period, most deaths were associated with the underlying diagnosis of TOF and mediated by arrhythmias and congestive heart failure,” concluded lead author Clayton Smith, MD, of Emory University, and colleagues. “Staged repair and non–valve-sparing operations were negatively associated with survival in the early post-repair phase. These data are important for patients with repaired TOF and their caretakers, and may guide surgical strategies for optimizing the long-term outcomes of this population.”
TOF is a cyanotic congenital heart disease characterized by four main findings; pulmonary stenosis, a narrowing of the exit from the right ventricle; a ventricular septal defect; right ventricular hypertrophy; and an overriding aorta, which allows blood from both ventricles to enter the aorta. Symptoms include episodes of bluish color to the skin. Other symptoms may include a heart murmur, finger clubbing, and easy tiring upon breastfeeding. The cause is typically not known.
Related Links:
Emory University
University of Minnesota
Researchers at Emory University (Atlanta, GA, USA), the University of Minnesota (UMN; Minneapolis, USA), and other institutions conducted a retrospective cohort study involving 3,283 patients (56.4% men) enrolled in the Pediatric Cardiac Care Consortium (PCCC) between 1982 and 2003 and whom survived surgical repair of simple TOF. Main outcomes and measures were transplant-free survival during the early (less than six years) and late phase following surgical repair, adjusted for era and patient characteristics.
The results revealed that one-year survival rate following TOF repair was 98.6%, decreasing to 97.8% at five years; 97.1% at 10 years; 95.5% at 20 years; and 94.5% at 25 years, with an early steep mortality hazard increase peaking shortly after repair, followed by a late, gradual hazard increase. Increased mortality risks were found in non-valve-sparing operations and staged repair. Genetic abnormalities were associated with increased mortality risk in both early and late post-surgical phases. The study was published on December 19, 2018, in JAMA Cardiology.
“Long-term transplant-free survival beyond the first six years is influenced primarily by the coexistence of an associated genetic condition. Within the 25-year follow-up period, most deaths were associated with the underlying diagnosis of TOF and mediated by arrhythmias and congestive heart failure,” concluded lead author Clayton Smith, MD, of Emory University, and colleagues. “Staged repair and non–valve-sparing operations were negatively associated with survival in the early post-repair phase. These data are important for patients with repaired TOF and their caretakers, and may guide surgical strategies for optimizing the long-term outcomes of this population.”
TOF is a cyanotic congenital heart disease characterized by four main findings; pulmonary stenosis, a narrowing of the exit from the right ventricle; a ventricular septal defect; right ventricular hypertrophy; and an overriding aorta, which allows blood from both ventricles to enter the aorta. Symptoms include episodes of bluish color to the skin. Other symptoms may include a heart murmur, finger clubbing, and easy tiring upon breastfeeding. The cause is typically not known.
Related Links:
Emory University
University of Minnesota
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







